WellMedRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.3/10
Best for: comparing compounded and brand GLP-1 plans with a published state list
WellMedRx falls below our bar on disclosure. It charges from $49 a month; its brand-name semaglutide, at $1,399, is 8% above the $1,299 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
WellMedr, now styled welludr., advertises compounded semaglutide from $49 a month and tirzepatide from $89, but its own billing policy says a per-month figure on a prepaid plan is the total divided by the months, and the real plan terms appear only at checkout. Brand Ozempic and Zepbound are offered month to month. Three Florida pharmacies are named, and service covers all 50 states plus DC, Puerto Rico and Guam.
Is WellMedRx legit?
Yes. WellMedRx is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a WellMedRx promo or coupon code?
WellMedRx has no code to type in. The current offer: 50% off your first month on compounded semaglutide (GLP-1) and tirzepatide (GIP/GLP-1). Brand-name Ozempic/Zepbound excluded. It applies at checkout on its own. Coupon sites advertising a "WellMedRx promo code" are not a source we can vouch for.
See how WellMedRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
WellMedRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $49/mo
- Availability
- All 50 states + DC
- FDA status
- No FDA warning letters found
How WellMedRx scores
Six columns, each one computed from something WellMedRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$1,399/month is 8% above the $1,299 median for brand-name semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states and DC.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on WellMedRx
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for WellMedRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with WellMedRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1WellMedRx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask WellMedRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $1,399, tirzepatide $1,599. That leaves out membership fees, first-month rates and insurance copays.
- WellMedRx serves all 50 states and DC.
Contacting WellMedRx
- WellMedRx offers email support
Cancelling WellMedRx
Taken from the terms WellMedRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- 21-day plan renews until canceled; 3-, 6- and 12-month plans are prepaid
- Refund policy
- Full refund before the pharmacy starts filling; after that, only unfulfilled portions
- Early-termination fee
- None
Medications WellMedRx lists
WellMedRx lists Ozempic, Zepbound, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides WellMedRx offers
WellMedRx sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
'Monthly Plan Starting At $49 a month'. The site's plans are a 21-day plan and prepaid 3-, 6- and 12-month plans.
'Monthly Plan Starting At $89 a month ... Same price regardless of dosage.'
'Ozempic Starting at $1,399'.
'Zepbound starting at $1,599'.
Check the price yourself before you pay
Every figure here comes from WellMedRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Serves all 50 states and DC
- We found no FDA warning letters issued to WellMedRx
Against it
- Semaglutide costs $1,399 a month, 8% above the $1,299 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $1,599 a month, 23% above the $1,299 median for brand-name tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What WellMedRx charges
WellMedRx charges $49/month.
- Compounded semaglutide: $49/month
- Compounded tirzepatide: $89/month
- Ozempic: $1,399/month
- Zepbound: $1,599/month
For brand-name semaglutide, the median across the sellers we compare is $1,299/month, so WellMedRx's $1,399 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare WellMedRx's cancellation terms with other sellers' cancellation and refund policies.
VevaRx dispenses semaglutide and tirzepatide from $47/month, which makes it the fair comparison to run before you commit here.
What WellMedRx dispenses
WellMedRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
WellMedRx tells you that it treats patients in all 50 states. We found no FDA warning letters issued to WellMedRx. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If WellMedRx will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
WellMedRx also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You need insurance to cover the cost. Check whether WellMedRx bills your plan before you start.
It fits if
- you need access wherever you live
Our read
WellMedRx lands mid-market on price. The catch is disclosure, which is why WellMedRx scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
WellMedRx falls below our bar on disclosure. It charges from $49 a month; its brand-name semaglutide, at $1,399, is 8% above the $1,299 median among the sellers we compare.
Before you pay WellMedRx
Starting at $49 a month. Check today's price, then start the intake.
If you are weighing other sellers, our guide to alternatives to WellMedRx sets more sellers in the same category beside WellMedRx on price, states and what the price includes.
Alternatives to WellMedRx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Frequently Asked Questions
How to check WellMedRx yourself
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Alabama, Arkansas, California, Florida, Kansas, New Hampshire, North Dakota, South Carolina and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this WellMedRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See WellMedRx's current pricing
Plans start at $49 a month. Whether you qualify is a clinician's decision, made after your intake.